Terms: = Prostate cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Diagnosis
4 results:
1. A Brief Review of Radioactive Materials for Therapeutic and Diagnostic Purposes.
Bharti M; Alam MA; Rao GSNK; Sharma PK
Curr Radiopharm; 2023; 16(1):23-37. PubMed ID: 36306460
[TBL] [Abstract] [Full Text] [Related]
2. Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging.
Frigerio B; Franssen G; Luison E; Satta A; Seregni E; Colombatti M; Fracasso G; Valdagni R; Mezzanzanica D; Boerman O; Canevari S; Figini M
Oncotarget; 2017 Feb; 8(7):10919-10930. PubMed ID: 28051996
[TBL] [Abstract] [Full Text] [Related]
3. Exisulind: Aptosyn, FGN 1, Prevatac, sulindac sulfone.
Drugs R D; 2004; 5(4):220-6. PubMed ID: 15230629
[TBL] [Abstract] [Full Text] [Related]
4. Plasma and urine cyclic nucleotide levels in malignant disease and cirrhosis of the liver.
Wood PJ; Ross G; Smith CL
J Clin Pathol; 1979 Oct; 32(10):998-1002. PubMed ID: 230205
[TBL] [Abstract] [Full Text] [Related]